Rusfertide still needs to be Verified
An FDA verdict is due in the third quarter, as Protagonist looks likely to opt out.
An FDA verdict is due in the third quarter, as Protagonist looks likely to opt out.
Rusfertide, the subject of a 2024 tie-up, scores in phase 3.
Rusfertide’s big readout will now not come until 2025.